Nikki Choa
Family · Los Angeles, CANPI 1285070292
Payments from drug & device makers
Across 75 payments — averaging $27.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$347
- Incyte Corporation$201
- Sanofi$174
- Coloplast$169
- Galderma Laboratories, L.p.$156
- SK Life Science, Inc.$144
- plus $864 from 16 others
What the payments were for
- Food & beverage$2,055100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 8 | $347 |
| Incyte Corporation | 8 | $201 |
| Sanofi | 8 | $174 |
| Coloplast | 7 | $169 |
| Galderma Laboratories, L.p. | 1 | $156 |
| SK Life Science, Inc. | 6 | $144 |
| AbbVie | 5 | $126 |
| Bayer | 6 | $121 |
| Merck | 5 | $110 |
| EMD Serono, Inc. | 2 | $83 |
| Servier Pharmaceuticals LLC | 4 | $78 |
| Progenics Pharmaceuticals, Inc. | 2 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| Eisai Inc. | 2 | $37 |
| Exelixis Inc. | 2 | $35 |
| Convatec Inc. | 1 | $34 |
| Sumitomo Pharma America, Inc. | 1 | $30 |
| Novartis | 1 | $29 |
| Jazz Pharmaceuticals Inc. | 1 | $25 |
| Neurelis, Inc. | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| UCB, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,055 in reported general payments places this provider in the 85th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 36 | $25,077 |
| Tamsulosin Hcl | 71 | $972 |
| Finasteride | 35 | $413 |
| Tolterodine Tartrate ErTolterodine Tartrate | 13 | $385 |
| Oxybutynin Chloride | 12 | $299 |
Paid to pharmacies, not to this prescriber.
Other family in Los Angeles
- Annette ShonLos Angeles$406K
- Phyllis CasonLos Angeles$187K
- Theodore SolomonLos Angeles$131K
- Angela SarffLos Angeles$51K
- Karla MenjivarLos Angeles$36K
- Janet GripshoverLos Angeles$30K
- Jualynda SmithLos Angeles$28K
- Phoebedel ReyesLos Angeles$26K
- Lori RobertsonChino Hills$475K
- Nancy GardettoSan Diego$394K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.